1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Number 08722684

US 08722684 B2
Application Number12301061
Publication NumberUS 20100297240 A1
Pendency6 years, 11 months, 4 days
Filled DateJun 15, 2007
Priority DateJun 16, 2006
Publication DateNov 25, 2010
Expiration DateJun 15, 2026
Inventor/ApplicantsLone Munch Ringgaard
Jorgen Brodersen
Arne Mork
Michael J. Mealy
Andre Faldt
Benny Bang-Andersen
Heidi Lopez De Diego
Morten Jorgensen
Rene Holm
Michael Harold Rock
Tine Bryan Stensbol
Nicholas Moore
Heidi Lopez de Diego
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
H. Lundbeck As
Current
H. Lundbeck As
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.